Back to Search
Start Over
Cyclin-dependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)-dependent cell growth control: a new role for p120ctn in cancer
- Source :
- Cancer Research, Cancer Research, American Association for Cancer Research, 2007, 67 (20), pp.9781-90. ⟨10.1158/0008-5472.CAN-07-0233⟩, Cancer Research, 2007, 67 (20), pp.9781-90. ⟨10.1158/0008-5472.CAN-07-0233⟩
- Publication Year :
- 2007
- Publisher :
- HAL CCSD, 2007.
-
Abstract
- Depending on its cellular localization, p120 catenin (p120ctn) can participate in various processes, such as cadherin-dependent cell-cell adhesion, actin cytoskeleton remodeling, and intracellular trafficking. Recent studies also indicate that p120ctn could regulate cell proliferation and contact inhibition. This report describes a new function of p120ctn in the regulation of cell cycle progression. Overexpression of the p120ctn isoform 3A in human colon adenocarcinoma cells (HT-29) results in cytoplasmic accumulation of the protein, as observed in many tumors. This cytoplasmic increase is correlated with a reduction in proliferation and inhibition of DNA synthesis. Under these conditions, experiments on synchronized cells revealed a prolonged S phase associated with cyclin E stabilization. Both confocal microscopy and biochemical analysis showed that cyclin E and cyclin-dependent kinase 2 colocalized with p120ctn in centrosomes during mitosis. These proteins are associated in a functional complex evidenced by coimmunoprecipitation experiments and the emergence of Thr199-phosphorylated nucleophosmin/B23. Such post-translational modification of this centrosomal target has been shown to trigger the initiation of centrosome duplication. Therefore, p120ctn-mediated accumulation of cyclin E in centrosomes may participate in abnormal amplification of centrosomes and the inhibition of DNA replication, thus leading to aberrant mitosis and polyploidy. Because these modifications are often observed in cancer, p120ctn may represent a new therapeutic target for future therapy. [Cancer Res 2007;67(20):9781–90]
- Subjects :
- Cancer Research
Cytoplasm
Delta Catenin
Cyclin E
Cyclin D
Cyclin A
MESH: HT29 Cells
Cyclin B
MESH: Cell Cycle
MESH: Centrosome
MESH: Gene Amplification
0302 clinical medicine
MESH: Up-Regulation
Phosphorylation
0303 health sciences
biology
MESH: Genomic Instability
Cell Cycle
Catenins
16. Peace & justice
3. Good health
Cell biology
Up-Regulation
Oncology
030220 oncology & carcinogenesis
Colonic Neoplasms
MESH: Cell Growth Processes
Disease Progression
MESH: Cell Adhesion Molecules
MESH: Disease Progression
HT29 Cells
animal structures
MESH: Cyclin-Dependent Kinase 2
Recombinant Fusion Proteins
Green Fluorescent Proteins
Cell Growth Processes
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
MESH: Phosphoproteins
Article
Genomic Instability
03 medical and health sciences
MESH: Green Fluorescent Proteins
MESH: Recombinant Fusion Proteins
Humans
Mitosis
[SDV.BC] Life Sciences [q-bio]/Cellular Biology
MESH: Catenins
030304 developmental biology
Centrosome
MESH: Colonic Neoplasms
MESH: Humans
MESH: Phosphorylation
MESH: Cytoplasm
Cyclin-dependent kinase 2
Cyclin-Dependent Kinase 2
Gene Amplification
Phosphoproteins
MESH: Cyclin E
Cyclin-dependent kinase complex
biology.protein
Cancer research
Cell Adhesion Molecules
Cyclin A2
Subjects
Details
- Language :
- English
- ISSN :
- 00085472 and 15387445
- Database :
- OpenAIRE
- Journal :
- Cancer Research, Cancer Research, American Association for Cancer Research, 2007, 67 (20), pp.9781-90. ⟨10.1158/0008-5472.CAN-07-0233⟩, Cancer Research, 2007, 67 (20), pp.9781-90. ⟨10.1158/0008-5472.CAN-07-0233⟩
- Accession number :
- edsair.doi.dedup.....994df857f52965852858fe14364bd1ae
- Full Text :
- https://doi.org/10.1158/0008-5472.CAN-07-0233⟩